Rekombinanter Nipah Virus Post-Fusion Glycoprotein (NIV pF) Antikörper

Produktnummer ABIN7824740

Der Maus Monoklonal anti-Nipah Virus Post-Fusion Glycoprotein Antikörper (Klon 2B2) (ABIN7824740) detektiert spezifisch Nipah Virus Post-Fusion Glycoprotein in ELISA. Dieser Antikörper reagiert spezifisch mit Proben aus Nipah Virus (NiV).

Kurzübersicht für Rekombinanter Nipah Virus Post-Fusion Glycoprotein (NIV pF) Antikörper (ABIN7824740)

Target: Nipah Virus Post-Fusion Glycoprotein (NIV pF)

Antikörpertyp: Recombinant Antibody

Reaktivität: Nipah Virus (NiV)

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Unkonjugiert

Applikation: ELISA

Klon: 2B2

Produktdetails

Expressionssystem: HEK293

Verwendungszweck: Monoclonal Anti-Nipah Post Fusion glycoprotein Antibody, Human IgG1 (2B2) (MALS verified)

Produktmerkmale: Monoclonal Anti-Nipah Post Fusion glycoprotein Antibody, Human IgG1 (2B2) is a chimeric monoclonal antibody recombinantly expressed from HEK293, which combines the variable region of a mouse monoclonal antibody with Human constant domain.

Aufreinigung: Protein A purified / Protein G purified

Reinheit: 95% as determined by SDS-PAGE.

Sterilität: 0.22 μm filtered

Isotyp: IgG1, kappa

Anwendungsinformationen

Applikationshinweise: ELISA: 0.03-31 ng/ml

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Buffer: Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

Handhabung: Please avoid repeated freeze-thaw cycles.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: For long term storage, the product should be stored at lyophilized state at -20°C or lower. This product is stable after storage at: -20°C to -70°C for 12 months in lyophilized state; -70°C for 3 months under sterile conditions after reconstitution.

Antigendetails

Target: Nipah Virus Post-Fusion Glycoprotein (NIV pF)

Andere Bezeichnung: Nipah Virus Post-Fusion Glycoprotein

Hintergrund: Hendra virus (HeV) and Nipah virus (NiV) are henipaviruses discovered in the mid-to late 1990s that possess a broad host tropism and are known to cause severe and often fatal disease in both humans and animals. HeV and NiV infect host cells through the co